Maintaining quality and safety in retina clinics during a pandemic

To maintain treatment quality and patient and staff safety in the SARS-CoV-2 era, it is important to minimise clinic visits and maximise use of imaging modalities. In addition, extending treatment intervals with longer-acting agents is key to maximising safety and patients’ vision outcomes.

Harnessing the power of light in dry age-related macular degeneration

Photobiomodulation has been demonstrated to improve quality of vision in several patients suffering from dry AMD.

Uncovering the role of LRG1 in disease mechanisms

Novel monoclonal antibody can halt the growth of abnormal blood vessels

Considering the presence of retinal fluid when treating nAMD patients

August 20, 2020

Recent international ophthalmic congresses have featured advocates for and against the need for complete fluid resolution when treating nAMD, with some ophthalmologists arguing for a zero-tolerance approach to the presence of fluid, and others claiming some residual fluid can be tolerated and may be helpful in some patients.

Small-aperture IOL poised to fill unmet need

August 06, 2020

The one-piece, small-aperture IOL IC-8 was found in a retrospective comparative review of studies to enhance vision at all distances, with improved visual acuities and a broad range of continuous functional vision.

Insights into the future of eye care

July 29, 2020

A UK health data research hub containing vast numbers of fundus and OCT images opens the door to improved screening and diagnoses of eye diseases and even ‘oculomic’ services for systemic health.